Elizabeth Masson Hurlburt is EVP, Head of Clinical Ops. of CorMedix Inc.. Currently has a direct ownership of 53,397 shares of CRMD, which is worth approximately $533,436. The most recent transaction as insider was on Jan 12, 2024, when has been sold 4,603 shares (Common Stock) at a price of $3.47 per share, resulting in proceeds of $15,972. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 53.4K
0% 3M change
Infinity% 12M change
Total Value Held $533,436

Elizabeth Masson-Hurlburt Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 12 2024
SELL
Payment of exercise price or tax liability
$15,972 $3.47 p/Share
4,603 Reduced 7.94%
53,397 Common Stock
Jan 12 2024
BUY
Grant, award, or other acquisition
-
50,000 Added 46.3%
58,000 Common Stock
May 21 2021
SELL
Open market or private sale
$55,360 $6.92 p/Share
8,000 Reduced 100.0%
0 Common Stock
EM

Elizabeth Masson Hurlburt

EVP, Head of Clinical Ops.
Berkeley Heights, NJ

Track Institutional and Insider Activities on CRMD

Follow CorMedix Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRMD shares.

Notify only if

Insider Trading

Get notified when an Cor Medix Inc. insider buys or sells CRMD shares.

Notify only if

News

Receive news related to CorMedix Inc.

Track Activities on CRMD